Published in Ann Intern Med on January 06, 2015
Hyaluronic Acid Injections Are Associated with Delay of Total Knee Replacement Surgery in Patients with Knee Osteoarthritis: Evidence from a Large U.S. Health Claims Database. PLoS One (2015) 1.46
The rise, fall, and possible resurrection of renal denervation. Nat Rev Cardiol (2016) 1.06
Pharmacologic interventions for knee osteoarthritis. Ann Intern Med (2015) 1.04
Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. Osteoarthritis Cartilage (2016) 0.85
Value-based Healthcare: The Challenge of Identifying and Addressing Low-value Interventions. Clin Orthop Relat Res (2017) 0.84
Osteoarthritis year in review 2015: clinical. Osteoarthritis Cartilage (2016) 0.83
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). Ann Rheum Dis (2017) 0.82
Second-line treatments for advanced gastric cancer: Interpreting outcomes by network meta-analysis. World J Clin Oncol (2015) 0.82
Abnormal Subcortical Brain Morphology in Patients with Knee Osteoarthritis: A Cross-sectional Study. Front Aging Neurosci (2016) 0.79
Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study. BMC Musculoskelet Disord (2016) 0.78
Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed (2016) 0.78
Hyaluronic acid compared with corticosteroid injections for the treatment of osteoarthritis of the knee: a randomized control trail. Springerplus (2016) 0.78
Steroids, lidocain and ioxaglic acid modify the viscosity of hyaluronic acid: in vitro study and clinical implications. Springerplus (2016) 0.78
Intra-articular Hyaluronic Acid in Treating Knee Osteoarthritis: a PRISMA-Compliant Systematic Review of Overlapping Meta-analysis. Sci Rep (2016) 0.78
Intra-Articular Therapies in the Treatment of Hand Osteoarthritis: A Systematic Literature Review. Drugs Aging (2016) 0.77
Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol. Clin Med Insights Arthritis Musculoskelet Disord (2016) 0.77
Relative efficacy of knee osteoarthritis treatments: are all placebos created equal? Ann Intern Med (2015) 0.77
Evidence for safety of retreatment with a single intra-articular injection of Gel-200 for treatment of osteoarthritis of the knee from the double-blind pivotal and open-label retreatment clinical trials. BMC Musculoskelet Disord (2016) 0.77
How does surgery compare with advanced intra-articular therapies in knee osteoarthritis: current thoughts. Ther Adv Musculoskelet Dis (2016) 0.77
Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis. PLoS One (2016) 0.77
Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada. Drug Des Devel Ther (2015) 0.77
Appropriate Use Criteria for Hyaluronic Acid in the Treatment of Knee Osteoarthritis in the United States. Cartilage (2016) 0.77
Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. Sci Rep (2015) 0.76
Unraveling the confusion behind hyaluronic acid efficacy in the treatment of symptomatic knee osteoarthritis. J Pain Res (2016) 0.76
In knee osteoarthritis, pharmacological interventions, with the exception of acetaminophen, significantly improve pain; with intra-articular administration being more effective. Evid Based Med (2015) 0.75
Electrospun Microfiber Scaffolds with Anti-Inflammatory Tributanoylated N-Acetyl-d-Glucosamine Promote Cartilage Regeneration. Tissue Eng Part A (2016) 0.75
Practice guidelines for pharmacists: The management of osteoarthritis. Can Pharm J (Ott) (2017) 0.75
Further Effort is Needed to Improve Management of Chronic Pain in Primary Care. Results from the Arkys Project. Clin Pract (2016) 0.75
Imaging Guidance Improves the Results of Viscosupplementation with HANOX-M-XL in Patients with Ankle Osteoarthritis: Results of a Clinical Survey in 50 Patients Treated in Daily Practice. Clin Med Insights Arthritis Musculoskelet Disord (2016) 0.75
Pharmacologic interventions for knee osteoarthritis. Ann Intern Med (2015) 0.75
Intra articular hyaluronic acid in the management of knee osteoarthritis: Pharmaco-economic study from the perspective of the national health insurance system. PLoS One (2017) 0.75
The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study. Clin Drug Investig (2016) 0.75
Knee osteoarthritis: Therapeutic alternatives in primary care. World J Orthop (2017) 0.75
A multicentre randomised, 1-year comparative effectiveness, parallel-group trial protocol of a physical therapy approach compared to corticosteroid injections. BMJ Open (2016) 0.75
Sex-Specific Protection of Osteoarthritis by Deleting Cartilage Acid Protein 1. PLoS One (2016) 0.75
Efficacy and safety of aceclofenac in osteoarthritis: A meta-analysis of randomized controlled trials. Eur J Rheumatol (2017) 0.75
Anaesthetics, steroids and platelet-rich plasma (PRP) in ultrasound-guided musculoskeletal procedures. Br J Radiol (2016) 0.75
Using the MyoKinesthetic System to Treat Bilateral Chronic Knee Pain: A Case Study. J Chiropr Med (2016) 0.75
Potential Impact of Biologically Derived Hyaluronic Acid on Quality of Life in Patients with Knee Osteoarthritis in the United States. Adv Ther (2016) 0.75
Effectiveness and Safety of Manufactured Chinese Herbal Formula for Knee Osteoarthritis: Insights from a Systematic Review. Evid Based Complement Alternat Med (2015) 0.75
Hyaluronic acid injection therapy for osteoarthritis of the knee: concordant efficacy and conflicting serious adverse events in two systematic reviews. Syst Rev (2016) 0.75
Pharmacotherapies in Geriatric Chronic Pain Management. Clin Geriatr Med (2016) 0.75
A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritis. Med Devices (Auckl) (2016) 0.75
Sensitivity to Change of Patient-Preference Measures for Pain in Patients With Knee Osteoarthritis: Data From Two Trials. Arthritis Care Res (Hoboken) (2016) 0.75
Clinical and cost outcomes from different hyaluronic acid treatments in patients with knee osteoarthritis: evidence from a US health plan claims database. Drugs Context (2016) 0.75
Notochordal cell conditioned medium (NCCM) regenerates end-stage human osteoarthritic articular chondrocytes and promotes a healthy phenotype. Arthritis Res Ther (2016) 0.75
Safety of Repeated Injections of Sodium Hyaluronate (SUPARTZ) for Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Cartilage (2016) 0.75
Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. BMC Musculoskelet Disord (2017) 0.75
Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a Canadian evidence-based perspective. Ther Adv Musculoskelet Dis (2017) 0.75
Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial. J Int Med Res (2017) 0.75
Cost-Utility of a Single-Injection Combined Corticosteroid-Hyaluronic Acid Formulation vs a 2-Injection Regimen of Sequential Corticosteroid and Hyaluronic Acid Injections. Clin Med Insights Arthritis Musculoskelet Disord (2017) 0.75
Polysaccharides As Viscosupplementation Agents: Structural Molecular Characteristics but Not Rheology Appear Crucial to the Therapeutic Response. Front Med (Lausanne) (2017) 0.75
Use of Intra-Articular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice. Arthritis Care Res (Hoboken) (2017) 0.75
[Knee joint pain with signs of arthrosis]. Schmerz (2017) 0.75
[Injection treatment with hyaluronic acid]. Z Rheumatol (2015) 0.75
Osteoarthritis: Time to put steroid injections behind us? Nat Rev Rheumatol (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis (2013) 10.92
Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care (2002) 10.00
The case of the misleading funnel plot. BMJ (2006) 8.26
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA (2002) 5.81
Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology (2003) 5.40
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med (2007) 4.54
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc (2003) 4.44
A randomized trial of tai chi for fibromyalgia. N Engl J Med (2010) 4.37
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30
Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke (2009) 4.14
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum (2007) 3.61
Why clinicians are natural bayesians. BMJ (2005) 3.41
Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care (2007) 3.27
Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (2007) 3.22
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr (2007) 3.14
Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA (2008) 3.01
Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol (2009) 2.92
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. Value Health (2012) 2.86
Loss to analysis in randomized controlled trials in CKD. Am J Kidney Dis (2011) 2.85
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet (2009) 2.81
In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol (2005) 2.77
Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol (2008) 2.77
Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol (2007) 2.66
Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial. Arthritis Rheum (2009) 2.63
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med (2002) 2.49
Adjusting for publication bias in the presence of heterogeneity. Stat Med (2003) 2.42
Alcohol consumption as a trigger of recurrent gout attacks. Am J Med (2006) 2.39
Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med (2005) 2.38
Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis. Arthritis Rheumatol (2015) 2.34
Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol (2006) 2.27
Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA (2011) 2.27
Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation (2012) 2.24
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making (2012) 2.21
Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis (2008) 2.19
A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol (2003) 2.10
Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10
Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models. Arthritis Rheumatol (2015) 2.08
Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med (2004) 2.07
Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. Am J Prev Med (2005) 2.04
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2011) 2.01
Semi-automated screening of biomedical citations for systematic reviews. BMC Bioinformatics (2010) 2.00
Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum (2009) 1.99
Evaluating the performance of equations for estimating glomerular filtration rate. J Nephrol (2008) 1.95
Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf (2010) 1.95
Ethnic subgroup differences in hypertension in Pakistan. J Hypertens (2003) 1.94
A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med (2014) 1.93
Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol (2010) 1.93
Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2004) 1.93
Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88
Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol (2007) 1.86
Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke (2006) 1.86
Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. J Clin Epidemiol (2010) 1.85
Predicting nursing home admission: estimates from a 7-year follow-up of a nationally representative sample of older Americans. Alzheimer Dis Assoc Disord (2004) 1.85
Achieved versus intended pulse oximeter saturation in infants born less than 28 weeks' gestation: the AVIOx study. Pediatrics (2006) 1.83
Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials. Stroke (2013) 1.81
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int (2010) 1.81
Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens (2005) 1.77
Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. J Am Soc Nephrol (2005) 1.76
Tai Chi on psychological well-being: systematic review and meta-analysis. BMC Complement Altern Med (2010) 1.76
Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke (2011) 1.74
Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes (2009) 1.71
Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl (2004) 1.69
Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcomes (2013) 1.66
Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med (2005) 1.66
Still no closure on the question of PFO closure. N Engl J Med (2013) 1.64
American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res (Hoboken) (2012) 1.63
Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies. Circ Cardiovasc Genet (2010) 1.62
Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials. Ann Intern Med (2015) 1.61
Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl (2002) 1.57
Comparing the public health burden of chronic hepatitis C and HIV infection in France. J Hepatol (2004) 1.57
Reporting clinical trial results to inform providers, payers, and consumers. Health Aff (Millwood) (2005) 1.57
Relationship of bone mineral density to progression of knee osteoarthritis. Arthritis Rheum (2013) 1.55
Personalised medicine: not just in our genes. BMJ (2012) 1.51
Is lipstick associated with the development of systemic lupus erythematosus (SLE)? Clin Rheumatol (2008) 1.50
Effects of study precision and risk of bias in networks of interventions: a network meta-epidemiological study. Int J Epidemiol (2013) 1.50
Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol (2008) 1.49
Is it influenza or anthrax? A decision analytic approach to the treatment of patients with influenza-like illnesses. Ann Emerg Med (2004) 1.48